Most importantly, FOXH1 HA22T tumors were considerably suppressed when we administrated them with 2 mg/kg rapamycin (Figure 6A, 6B), strengthening the notion that the contribution of FOXH1 to HCC progression was at least partially dependent of mTOR signaling. This evidence concerns the gene FOXH1 and hepatocellular carcinoma.